Amedeo Smart

Free Medical Literature Service

 

Amedeo

HIV Infection
  Free Subscription

Articles published in
Lancet
    April 2024

  1. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367.
    >> Share

    March 2024
  2. BEYRER C, Kamarulzaman A, Isbell M, Amon J, et al
    Under threat: the International AIDS Society-Lancet Commission on Health and Human Rights.
    Lancet. 2024 Mar 20:S0140-6736(24)00302-7. doi: 10.1016/S0140-6736(24)00302.
    >> Share

  3. WATTS G
    Andrew Kerkhoff: award-winning TB and HIV physician-scientist.
    Lancet. 2024 Mar 15:S0140-6736(24)00539-7. doi: 10.1016/S0140-6736(24)00539.
    >> Share

  4. KANKASA C, Mennecier A, Sakana BLD, Moles JP, et al
    Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial.
    Lancet. 2024 Mar 11:S0140-6736(23)02464-9. doi: 10.1016/S0140-6736(23)02464.
    >> Share

  5. MUTALE W, Herce ME
    Closing the gap in paediatric HIV infections: how available tools and technology can accelerate progress towards ending AIDS by 2030.
    Lancet. 2024 Mar 11:S0140-6736(24)00366-0. doi: 10.1016/S0140-6736(24)00366.
    >> Share


  6. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden
    Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476.
    >> Share

    February 2024
  7. JOHNSTONE F
    Picture an epidemic: contemporary culture and HIV.
    Lancet. 2024 Feb 13:S0140-6736(24)00252-6. doi: 10.1016/S0140-6736(24)00252.
    >> Share

    January 2024
  8. PURIM E
    Full decriminalisation of the sex industry would not protect the health of prostitutes.
    Lancet. 2024;403:351-352.
    >> Share

  9. KAMYA MR, Kakuru A, Dorsey G
    Dihydroartemisinin-piperaquine for prevention of malaria in pregnant women living with HIV.
    Lancet. 2024 Jan 12:S0140-6736(24)00048-5. doi: 10.1016/S0140-6736(24)00048.
    >> Share

  10. BARSOSIO HC, Madanitsa M, Ondieki ED, Dodd J, et al
    Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial.
    Lancet. 2024 Jan 12:S0140-6736(23)02631-4. doi: 10.1016/S0140-6736(23)02631.
    >> Share

  11. KIRBY T
    Steady but variable progress towards global HIV targets.
    Lancet. 2024;403:16-17.
    >> Share

    December 2023
  12. KAMARULZAMAN A, Maleche A, Beyrer C
    Still relevant: the 75th anniversary of the Universal Declaration of Human Rights.
    Lancet. 2023;402:2171-2173.
    >> Share

    November 2023
  13. KIRBY T
    Bruce Richman: building the U=U movement for HIV prevention.
    Lancet. 2023 Nov 30:S0140-6736(23)02699-5. doi: 10.1016/S0140-6736(23)02699.
    >> Share

  14. MODY A, Sohn AH, Iwuji C, Tan RKJ, et al
    HIV epidemiology, prevention, treatment, and implementation strategies for public health.
    Lancet. 2023 Nov 30:S0140-6736(23)01381-8. doi: 10.1016/S0140-6736(23)01381.
    >> Share

  15. THE LANCET
    Preventing healers from becoming killers.
    Lancet. 2023;402:1805.
    >> Share

  16. NUNEZ I, Valdes-Ferrer SI
    Classifying necrotising mpox as an AIDS-defining condition - Authors' reply.
    Lancet. 2023;402:1752.
    >> Share

  17. MITJA O, Paredes R, Cabtree B, Orkin C, et al
    Classifying necrotising mpox as an AIDS-defining condition.
    Lancet. 2023;402:1751-1752.
    >> Share

  18. WONG M, Damon IK, Zucker J, Foote MMK, et al
    ART initiation for people living with HIV with severe mpox.
    Lancet. 2023;402:1750.
    >> Share

  19. KASPER T, Yamey G, Dwyer S, McDade KK, et al
    Rethinking how development assistance for health can catalyse progress on primary health care.
    Lancet. 2023 Nov 10:S0140-6736(23)01813-5. doi: 10.1016/S0140-6736(23)01813.
    >> Share

    October 2023
  20. MEMISH ZA, Blumberg L, Al-Maani AS, Baru R, et al
    Moving cholera vaccines ahead of the epidemic curve.
    Lancet. 2023 Oct 17:S0140-6736(23)02244-4. doi: 10.1016/S0140-6736(23)02244.
    >> Share

  21. KIVUYO S, Birungi J, Okebe J, Wang D, et al
    Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa (INTE-AFRICA): a pragmatic cluster-randomised, controlled trial.
    Lancet. 2023;402:1241-1250.
    >> Share

  22. BALDEH M, Kizito S
    Call to action: HIV among adolescents in Sierra Leone.
    Lancet. 2023;402:1240.
    >> Share

  23. KISIGO GA, Peck RN
    Integrating HIV, hypertension, and diabetes primary care in Africa.
    Lancet. 2023;402:1211-1213.
    >> Share

    September 2023
  24. KAVANAGH MM, Wenham C, Massard da Fonseca E, Helfer LR, et al
    Increasing compliance with international pandemic law: international relations and new global health agreements.
    Lancet. 2023 Sep 4:S0140-6736(23)01527-1. doi: 10.1016/S0140-6736(23)01527.
    >> Share

    August 2023
  25. ZHU DT, Friedman J, Bourgois P, Montero F, et al
    The emerging fentanyl-xylazine syndemic in the USA: challenges and future directions.
    Lancet. 2023 Aug 24:S0140-6736(23)01686-0. doi: 10.1016/S0140-6736(23)01686.
    >> Share

  26. THE LANCET
    Ending the HIV pandemic: preparing for the future.
    Lancet. 2023;402:585.
    >> Share

  27. MARTIN CA, Medisauskaite A, Gogoi M, Teece L, et al
    Discrimination, feeling undervalued, and health-care workforce attrition: an analysis from the UK-REACH study.
    Lancet. 2023 Aug 18:S0140-6736(23)01365-X. doi: 10.1016/S0140-6736(23)01365.
    >> Share


  28. Cause-specific mortality by county, race, and ethnicity in the USA, 2000-19: a systematic analysis of health disparities.
    Lancet. 2023 Aug 3:S0140-6736(23)01088-7. doi: 10.1016/S0140-6736(23)01088.
    >> Share

    July 2023
  29. BROYLES LN, Luo R, Boeras D, Vojnov L, et al
    The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review.
    Lancet. 2023 Jul 21:S0140-6736(23)00877-2. doi: 10.1016/S0140-6736(23)00877.
    >> Share

  30. BEKKER LG, Smith P, Ntusi NAB
    HIV is sexually untransmittable when viral load is undetectable.
    Lancet. 2023 Jul 21:S0140-6736(23)01519-2. doi: 10.1016/S0140-6736(23)01519.
    >> Share

  31. SHARMA DC
    Ethnic conflict hampering health services in Manipur, India.
    Lancet. 2023;402:94.
    >> Share

    June 2023

  32. The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019.
    Lancet. 2023 Jun 29:S0140-6736(23)00860-7. doi: 10.1016/S0140-6736(23)00860.
    >> Share

    May 2023
  33. FLAHAULT A, Calmy A, Costagliola D, Drapkina O, et al
    No time for complacency on COVID-19 in Europe.
    Lancet. 2023 May 22:S0140-6736(23)01012-7. doi: 10.1016/S0140-6736(23)01012.
    >> Share

  34. ZEGGAGH J, Ferraris O, Salmona M, Tarantola A, et al
    Second clinical episode of hMPX virus in a man having sex with men.
    Lancet. 2023;401:1610.
    >> Share

    April 2023
  35. O'SHEA J, Daskalakis D, Brooks JT
    The emergence of mpox as an HIV-related opportunistic infection.
    Lancet. 2023;401:1264.
    >> Share

  36. WEBSTER P
    PEPFAR at 20.
    Lancet. 2023;401:1145-1146.
    >> Share

  37. NKENGASONG J, Ratevosian J
    Legal and policy barriers for an effective HIV/AIDS response.
    Lancet. 2023 Apr 5:S0140-6736(23)00729-8. doi: 10.1016/S0140-6736(23)00729.
    >> Share

    March 2023
  38. NUNEZ I, Valdes-Ferrer SI
    Fulminant mpox as an AIDS-defining condition: useful or stigmatising?
    Lancet. 2023;401:881-884.
    >> Share

  39. WATTS G
    Bern-Thomas Nyang'wa: getting things done in TB and HIV.
    Lancet. 2023 Mar 17:S0140-6736(23)00576-7. doi: 10.1016/S0140-6736(23)00576.
    >> Share

  40. MADANITSA M, Barsosio HC, Minja DTR, Mtove G, et al
    Effect of monthly intermittent preventive treatment with dihydroartemisinin-piperaquine with and without azithromycin versus monthly sulfadoxine-pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlle
    Lancet. 2023 Mar 10:S0140-6736(22)02535-1. doi: 10.1016/S0140-6736(22)02535.
    >> Share

    February 2023
  41. MITJA O, Alemany A, Marks M, Lezama Mora JI, et al
    Mpox in people with advanced HIV infection: a global case series.
    Lancet. 2023 Feb 20:S0140-6736(23)00273-8. doi: 10.1016/S0140-6736(23)00273.
    >> Share

    January 2023
  42. KIRBY T, Thornber-Dunwell M
    10 years on-high-risk practices on the London gay scene.
    Lancet. 2023;401:94-95.
    >> Share

    December 2022
  43. BYANYIMA W, Lauterbach K, Kavanagh MM
    Community pandemic response: the importance of action led by communities and the public sector.
    Lancet. 2022 Dec 14:S0140-6736(22)02575-2. doi: 10.1016/S0140-6736(22)02575.
    >> Share

  44. SAMARASEKERA U
    Pakistan's growing HIV epidemic.
    Lancet. 2022;400:2031.
    >> Share

    November 2022
  45. THORNHILL JP, Palich R, Ghosn J, Walmsley S, et al
    Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series.
    Lancet. 2022 Nov 17:S0140-6736(22)02187-0. doi: 10.1016/S0140-6736(22)02187.
    >> Share

  46. GOODALL RL, Meredith SK, Nunn AJ, Bayissa A, et al
    Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.
    Lancet. 2022 Nov 7. pii: S0140-6736(22)02078.
    >> Share

  47. JACKSON S, Kabir Z, Comiskey C
    Divergence in pace of decline in tuberculosis rates among migrants versus non-migrants in Ireland from 2011 to 2020.
    Lancet. 2022;400 Suppl 1:S52.
    >> Share

    October 2022
  48. MYERS B, Lombard CJ, Lund C, Joska JA, et al
    Comparing dedicated and designated approaches to integrating task-shared psychological interventions into chronic disease care in South Africa: a three-arm, cluster randomised, multicentre, open-label trial.
    Lancet. 2022;400:1321-1333.
    >> Share

  49. PAN D, Sze S, Nazareth J, Martin CA, et al
    The monkeypox case definition in the UK is broad - Authors' reply.
    Lancet. 2022;400:1301-1302.
    >> Share

  50. KIRBY T
    Anthony Fauci: moving on.
    Lancet. 2022;400:1182-1183.
    >> Share

    September 2022
  51. LUO R, Fong Y, Boeras D, Jani I, et al
    The clinical effect of point-of-care HIV diagnosis in infants: a systematic review and meta-analysis.
    Lancet. 2022;400:887-895.
    >> Share

  52. TECHNAU KG, Mazanderani AH
    Point-of-care HIV diagnosis for infants: the outcomes we need to achieve.
    Lancet. 2022;400:864-865.
    >> Share

    August 2022
  53. THORNTON J
    Botswana's HIV/AIDS success.
    Lancet. 2022;400:480-481.
    >> Share

  54. TARIN-VICENTE EJ, Alemany A, Agud-Dios M, Ubals M, et al
    Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study.
    Lancet. 2022 Aug 8. pii: S0140-6736(22)01436.
    >> Share

    July 2022
  55. MAYER KH, Phanuphak N, Mgodi N, Grinsztejn B, et al
    New HIV prevention approaches: promise, praxis, and pitfalls.
    Lancet. 2022;400:257-259.
    >> Share


  56. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020.
    Lancet. 2022;400:185-235.
    >> Share

  57. BOOTH A
    New HIV law welcomed in Argentina.
    Lancet. 2022;400:149.
    >> Share

  58. GOGA A, Bekker LG, Garrett N, Reddy T, et al
    Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa.
    Lancet. 2022 Jul 6. pii: S0140-6736(22)01190.
    >> Share

    June 2022
  59. CHARANI E, McKee M, Balasegaram M, Mendelson M, et al
    Global burden of antimicrobial resistance: essential pieces of a global puzzle.
    Lancet. 2022;399:2346-2347.
    >> Share

  60. PAN D, Sze S, Nazareth J, Martin CA, et al
    Monkeypox in the UK: arguments for a broader case definition.
    Lancet. 2022 Jun 15. pii: S0140-6736(22)01101.
    >> Share

    May 2022
  61. NELLUMS LB, Latif A, Nkhoma K, Timmons S, et al
    COVID-19 boosters and building trust among UK minority ethnic communities.
    Lancet. 2022 May 25. pii: S0140-6736(22)00945.
    >> Share


  62. Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2022 May 23. pii: S0140-6736(22)00532.
    >> Share

  63. WATTS G
    Luc Antoine Montagnier.
    Lancet. 2022;399:1862.
    >> Share

    April 2022
  64. BUCHBINDER SP, McElrath MJ, Dieffenbach C, Corey L, et al
    COVID-19 vaccination and HIV-1 acquisition - Authors' reply.
    Lancet. 2022;399:e36.
    >> Share

  65. LOGUNOV DY, Livermore DM, Ornelles DA, Bayer W, et al
    COVID-19 vaccination and HIV-1 acquisition.
    Lancet. 2022;399:e34-e35.
    >> Share

  66. BLAKNEY AK, Bekker LG
    DNA vaccines join the fight against COVID-19.
    Lancet. 2022;399:1281-1282.
    >> Share

  67. MUDZINGWA EK, Parker IK
    Long-acting injections for HIV prevention among women in sub-Saharan Africa.
    Lancet. 2022 Apr 1. pii: S0140-6736(22)00613.
    >> Share

  68. DELANY-MORETLWE S, Hughes JP, Bock P, Ouma SG, et al
    Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
    Lancet. 2022 Apr 1. pii: S0140-6736(22)00538.
    >> Share

    March 2022
  69. KRAUSE PR, Rees H, Figueroa JP, Swaminathan S, et al
    Booster vaccines for COVID-19 vaccine breakthrough cases? - Authors' reply.
    Lancet. 2022;399:1225.
    >> Share

  70. WATERS L, Marra F, Pozniak A, Cockburn J, et al
    Ritonavir and COVID-19: pragmatic guidance is important.
    Lancet. 2022 Mar 22. pii: S0140-6736(22)00280.
    >> Share

  71. BEKKER LG, Garrett N, Goga A, Fairall L, et al
    Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.
    Lancet. 2022;399:1141-1153.
    >> Share


  72. Progress in health among regions of Ethiopia, 1990-2019: a subnational country analysis for the Global Burden of Disease Study 2019.
    Lancet. 2022 Mar 11. pii: S0140-6736(21)02868.
    >> Share

  73. FALLAH MP, Reinhart E
    Apartheid logic in global health.
    Lancet. 2022;399:902-903.
    >> Share

    February 2022
  74. CHEMAITELLY H, Abu-Raddad LJ
    Waning effectiveness of COVID-19 vaccines.
    Lancet. 2022;399:771-773.
    >> Share

  75. MADHI SA, Ihekweazu C, Rees H, Pollard AJ, et al
    Decoupling of omicron variant infections and severe COVID-19.
    Lancet. 2022 Feb 18. pii: S0140-6736(22)00109.
    >> Share

  76. MINALGA B, Chung C, Davids JD, Martin A, et al
    Research on transgender people must benefit transgender people.
    Lancet. 2022;399:628.
    >> Share

  77. SIVA N
    Gilead and ViiV Healthcare reach settlement over HIV drug.
    Lancet. 2022;399:618.
    >> Share

  78. HUMPHREYS K, Shover CL, Andrews CM, Bohnert ASB, et al
    Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.
    Lancet. 2022;399:555-604.
    >> Share

  79. BEYRER C
    Archbishop Desmond Tutu and the universality of health and human rights.
    Lancet. 2022;399:503-504.
    >> Share

  80. VAN DER MERWE LL, Cloete A, Skinner D
    How HIV advocacy can be used to ensure quality transgender health care: lessons from South Africa.
    Lancet. 2022 Feb 4. pii: S0140-6736(22)00177.
    >> Share

    January 2022
  81. WOLTER N, Jassat W, Walaza S, Welch R, et al
    Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.
    Lancet. 2022 Jan 19. pii: S0140-6736(22)00017.
    >> Share

  82. MCCALL C
    Disrupted care in Papua New Guinea: the harms of COVID-19.
    Lancet. 2022;399:226-227.
    >> Share

    December 2021
  83. HOSSEINPOOR AR, Bergen N, Kirkby K, Schlotheuber A, et al
    Monitoring inequalities is a key part of the efforts to end AIDS, tuberculosis, and malaria.
    Lancet. 2021 Dec 8. pii: S0140-6736(21)02756.
    >> Share

  84. MENDELSON M, Venter F, Moshabela M, Gray G, et al
    The political theatre of the UK's travel ban on South Africa.
    Lancet. 2021 Dec 3. pii: S0140-6736(21)02752.
    >> Share

    November 2021
  85. SIMBAYI LC, Moyo S, van Heerden A, Zuma K, et al
    Global HIV efforts need to focus on key populations in LMICs.
    Lancet. 2021 Nov 29. pii: S0140-6736(21)02692.
    >> Share

  86. JOLLY J
    A reproductive justice response to HIV/AIDS and COVID-19.
    Lancet. 2021;398:1958-1959.
    >> Share

  87. LANE R
    Pascale Ondoa: strengthening laboratory medicine in Africa.
    Lancet. 2021;398:1955.
    >> Share

  88. FALCARO M, Castanon A, Ndlela B, Checchi M, et al
    The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02178.
    >> Share

    October 2021

  89. Global, regional, and national mortality among young people aged 10-24 years, 1950-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2021;398:1593-1618.
    >> Share

  90. ADEPOJU P
    Nkengasong tipped to lead PEPFAR.
    Lancet. 2021;398:e15.
    >> Share

    July 2021
  91. SAMARASEKERA U
    Etheldreda Nakimuli-Mpungu: innovator in mental health.
    Lancet. 2021;398:109.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016